Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia

被引:101
作者
Hopkins, PN
Stephenson, S
Wu, LL
Riley, WA
Xin, YP
Hunt, SC
机构
[1] Univ Utah, Sch Med, Div Cardiol, Salt Lake City, UT USA
[2] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA
[3] Wake Forest Univ, Sch Med, Dept Neurol, Winston Salem, NC USA
关键词
D O I
10.1016/S0002-9149(00)01429-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
at onset of clinically manifested coronary artery disease (CAD) varies widely among patients with familial hypercholesterolemia (FH). A number of factors in addition to high low-density lipoprotein cholesterol (LDL) have been suggested as predictors of risk among patients with FH, but a comprehensive examination of their utility is lacking. We therefore measured plasma lipids, carotid intima-medial thickness, and a variety of coronary risk factors in 262 patients with FH greater than or equal to 30 years old (68 of whom had premature CAD). Age (p <0.0001) and gender were the most important determinants of premature CAD risk, with men having 5.64 times the risk of women (p <0.0001). In addition, cigarette smoking (odds ratio [OR] 2.71, p = 0.026), smaller LDL as determined by the LDL cholesterol/LDL apolipoprotein B ratio (OR 2.60, p = 0.014), and white blood cell count (p = 0.014) were also statistically significant risk factors. Lipoprotein(a) and the presence of xanthoma were associated with risk only in very early coronary cases. After correction for age, carotid intima-media thickness was not associated with CAD risk. Insulin, fibrinogen, homocysteine, plasma C-reactive protein, and the angiotensin-converting enzyme insertion/deletion polymorphism were unrelated to risk in this cohort. These results provide little justification for extensive investigation of risk factors among patients with FH, at least for the risk factors examined here. Rather, the inherent high LDL cholesterol of these patients should be the focus of preventive efforts. The novel finding of increased risk with smaller LDL may prove useful but needs further confirmation. (C) 2001 by Excerpta Medico, Inc.
引用
收藏
页码:547 / 553
页数:7
相关论文
共 30 条
[1]  
[Anonymous], 1991, J Neuroimaging, V1, P68
[2]   Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect [J].
Carmena, R ;
LussierCacan, S ;
Roy, M ;
Minnich, A ;
Lingenhel, A ;
Kronenberg, F ;
Davignon, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (01) :129-136
[3]   Coexisting dysbetalipoproteinemia and familial hypercholesterolemia - Clinical and laboratory observations [J].
Carmena, R ;
Roy, M ;
Roederer, G ;
Minnich, A ;
Davignon, J .
ATHEROSCLEROSIS, 2000, 148 (01) :113-124
[4]   EFFECTS OF SIMVASTATIN ON APO-B METABOLISM AND LDL SUBFRACTION DISTRIBUTION [J].
GAW, A ;
PACKARD, CJ ;
MURRAY, EF ;
LINDSAY, GM ;
GRIFFIN, BA ;
CASLAKE, MJ ;
VALLANCE, BD ;
LORIMER, AR ;
SHEPHERD, J .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (02) :170-189
[5]  
GEISS HC, 2000, ATHEROSCLEROSIS, V151, P36
[6]   Action of atorvastatin in combined hyperlipidemia - Preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles [J].
Guerin, M ;
Lassel, TS ;
Le Goff, W ;
Farnier, M ;
Chapman, MJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (01) :189-197
[7]  
Higgins M, 1996, AM J EPIDEMIOL, V143, P1219, DOI 10.1093/oxfordjournals.aje.a008709
[8]   GENETIC AND ENVIRONMENTAL-FACTORS AFFECTING THE INCIDENCE OF CORONARY-ARTERY DISEASE IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA [J].
HILL, JS ;
HAYDEN, MR ;
FROHLICH, J ;
PRITCHARD, PH .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02) :290-297
[9]   CORONARY-ARTERY DISEASE IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA [J].
HIROBE, K ;
MATSUZAWA, Y ;
ISHIKAWA, K ;
TARUI, S ;
YAMAMOTO, A ;
NAMBU, S ;
FUJIMOTO, K .
ATHEROSCLEROSIS, 1982, 44 (02) :201-210
[10]   Atorvastatin increases low-density lipoprotein size and enhances high-density lipoprotein cholesterol concentration in male, but not in female patients with familial hypercholesterolemia [J].
Hoogerbrugge, N ;
Jansen, H .
ATHEROSCLEROSIS, 1999, 146 (01) :167-174